Ivor Royston
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Genetics 28
- Chronic Lymphocytic Leukemia Research 28
- Virus-based gene therapy research 9
-
- Monoclonal and Polyclonal Antibodies Research 45
- Co-authors
- Ronald LevyDavid BodkinRobert E. SobolDaniel L. ShawlerAntonio J Grillo-LópezDavid G. MaloneyThomas A. DavisRussell J. Schilder
- Journals
- Blood (14 papers)Cancer (6 papers)JNCI Journal of the National Cancer Institute (5 papers)The Journal of Immunology (5 papers)Journal of Clinical Oncology (5 papers)
- Partner nations
- United StatesBrazilCanada
In The Last Decade
Ivor Royston
96 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Genetics 1.4k
- Immunology 2.2k
- Pathology and Forensic Medicine 1.7k
- Radiology, Nuclear Medicine and Imaging 1.7k
- Oncology 1.9k
Countries citing papers authored by Ivor Royston
This map shows the geographic impact of Ivor Royston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivor Royston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivor Royston more than expected).
Fields of papers citing papers by Ivor Royston
This network shows the impact of papers produced by Ivor Royston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivor Royston. The network helps show where Ivor Royston may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ivor Royston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 25 | |
| 2 | 2020 | 2 | |
| 3 | 2012 | 6 | |
| 4 | 1998 | 20 | |
| 5 | 1997 | 8 | |
| 6 | 1995 | 63 | |
| 7 | 1995 | 20 | |
| 8 | 1995 | 9 | |
| 9 | 1993 | 61 | |
| 10 | 1991 | 82 | |
| 11 | 1991 | 13 | |
| 12 | 1989 | 54 | |
| 13 | 1988 | 6 | |
| 14 | 1987 | 4 | |
| 15 | 1987 | 11 | |
| 16 | 1985 | 4 | |
| 17 | Phase I trials of thymosin fraction 5 and thymosin α1 | 1982 | 6 |
| 18 | 1982 | 74 | |
| 19 | Culture of normal and leukemic human lymphocyte colonies | 1981 | 1 |
| 20 | 1975 | 6 |
About Ivor Royston
Ivor Royston is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging, Immunology, Pathology and Forensic Medicine and Oncology, having authored 101 papers that have together received 5.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (45 papers), Chronic Lymphocytic Leukemia Research (28 papers), Lymphoma Diagnosis and Treatment (27 papers), Immunotherapy and Immune Responses (17 papers), CAR-T cell therapy research (14 papers), Viral-associated cancers and disorders (11 papers), Glycosylation and Glycoproteins Research (9 papers) and Virus-based gene therapy research (9 papers). The work is most often cited by research in Genetics (1.4k citations), Immunology (2.2k citations), Pathology and Forensic Medicine (1.7k citations), Radiology, Nuclear Medicine and Imaging (1.7k citations) and Oncology (1.9k citations). Ivor Royston has collaborated with scholars based in United States, Brazil and Canada. Frequent co-authors include Ronald Levy, David Bodkin, Robert E. Sobol, Daniel L. Shawler, Antonio J Grillo-López, David G. Maloney, Thomas A. Davis, Russell J. Schilder, Nalini Janakiraman and James A. Neidhart. Their work appears in journals such as Blood, Cancer, JNCI Journal of the National Cancer Institute, The Journal of Immunology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.